![Rolando Gutíerrez-Esteinou](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Rolando Gutíerrez-Esteinou
Corporate Officer/Principal chez
ORYZON GENOMICS S.A.
Profil
Rolando Gutíerrez-Esteinou is currently Chief Medical Officer-CNS Programs at Oryzon Genomics SA since 2026.
Former positions include Executive Director & VP-Global Therapeutic at Takeda Pharmaceutical Co., Ltd. from 2017 to 2018; VP-Clinical Development & Pharmacovigilance at Marinus Pharmaceuticals, Inc. from 2018 to 2020; Chief Medical Officer at ATAI Life Sciences AG; Vice President-Global Therapeutic Area at Fortrea Germany GmbH from 2010 to 2017; Senior Vice President-Medical & Pharmacovigilance at Aptinyx, Inc. in 2020; and Chief Medical Officer at Atai Beckley NV.
Education includes a doctorate from Universidad Nacional Autónoma de México.
Postes actifs de Rolando Gutíerrez-Esteinou
| Sociétés | Poste | Début |
|---|---|---|
| ORYZON GENOMICS S.A. | Corporate Officer/Principal | 12/02/2026 |
Anciens postes connus de Rolando Gutíerrez-Esteinou
| Sociétés | Poste | Fin |
|---|---|---|
| APTINYX | Directeur Technique/Scientifique/R&D | 01/12/2020 |
| MARINUS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/01/2020 |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Directeur/Membre du Conseil | 01/07/2018 |
Fortrea Germany GmbH
 Fortrea Germany GmbH Miscellaneous Commercial ServicesCommercial Services Operates scientific research institute | Corporate Officer/Principal | 01/03/2017 |
ATAI Life Sciences AG
 ATAI Life Sciences AG Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company specializes in development of pharmaceuticals for mental health treatment | Directeur Technique/Scientifique/R&D | - |
Formation de Rolando Gutíerrez-Esteinou
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
11
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Marinus Pharmaceuticals, Inc.
 Marinus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for rare genetic epilepsies and other seizure disorders | Health Technology |
Takeda Pharmaceutical Co., Ltd.
 Takeda Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research, development, manufacturing and marketing of pharmaceutical products | Health Technology |
Oryzon Genomics SA
 Oryzon Genomics SA BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops epigenetics-based therapeutics | Health Technology |
Universidad Nacional Autónoma de México
 Universidad Nacional Autónoma de México Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fortrea Germany GmbH
Fortrea Germany GmbH Miscellaneous Commercial ServicesCommercial Services Operates scientific research institute | Commercial Services |
Aptinyx, Inc.
 Aptinyx, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops therapies to treat disorders of the brain and nervous system | Health Technology |
ATAI Life Sciences AG
ATAI Life Sciences AG Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company specializes in development of pharmaceuticals for mental health treatment | Health Technology |
ATAI Life Sciences NV
 ATAI Life Sciences NV Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
